ArticleBMJ open2024

Precise infliximab exposure and pharmacodynamic control to achieve deep remission in paediatric Crohn's disease (REMODEL-CD): study protocol for a multicentre, open-label, pragmatic clinical trial in the USA.

Phillip Paul Minar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.